
Charming Medical, Diageo, Regencell Bioscience, UP Fintech, and China SXT Pharmaceuticals are the five Chinese stocks to watch today, according to MarketBeat’s stock screener tool. “Chinese stocks” refers to equity securities of companies that are incorporated in or derive significant business from China, and that are available to market investors through listings on mainland exchanges (Shanghai, Shenzhen), the Hong Kong Stock Exchange, or foreign exchanges via instruments such as American Depositary Receipts (ADRs). For investors, these include different share classes (A‑shares, H‑shares, red chips, P‑chips) and carry specific considerations like Chinese regulatory oversight, currency exposure, and geopolitical or market-structure risks. These companies had the highest dollar trading volume of any Chinese stocks within the last several days.
Charming Medical (MCTA)
We are a Hong Kong-based provider of Traditional Chinese Medicine (TCM)-inspired therapies and products. We offer a wide range of beauty, wellness, and postpartum services and products rooted and influenced by the principles and practices of TCM, such as the use of herbal ingredients, acupuncture techniques, Tuina massage, and dietary guidance.
Diageo (DEO)
Diageo plc, together with its subsidiaries, engages in the production, marketing, and sale of alcoholic beverages. The company offers scotch, gin, vodka, rum, raki, liqueur, wine, tequila, Chinese white spirits, cachaça, and brandy, as well as beer, including cider and flavored malt beverages. It also provides Chinese, Canadian, Irish, American, and Indian-Made Foreign Liquor whiskies, as well as flavored malt beverages, ready to drink, and non-alcoholic products.
Read Our Latest Research Report on DEO
Regencell Bioscience (RGC)
Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder.
Read Our Latest Research Report on RGC
UP Fintech (TIGR)
UP Fintech Holding Limited provides online brokerage services focusing on Chinese investors. The company has developed a brokerage platform, which allows investor to trade stocks, options, warrants, and other financial instruments that can be accessed through its APP and website. It offers brokerage and value-added services, including investor education, community engagement, and IR platform services.
Read Our Latest Research Report on TIGR
China SXT Pharmaceuticals (SXTC)
China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen.
Read Our Latest Research Report on SXTC
Further Reading
- MarketBeat’s Top Five Stocks to Own in February 2026
- Tesla’s Rally Setup Is Here—But Valuation Makes It Fragile
- META Resets Reality Labs, Grows Message Sales as Ad Engine Roars
- It’s Not Too Late to Buy These 2 Red-Hot AI Infrastructure Stocks
- Is AI Really Eating Software? A Wall Street Veteran Says No—Here’s Why
- Grab’s 2026 Selloff Had Reasons—But the Rebound Case Is Building
